Harnessing telemedicine to deliver patient-centered opioid agonist treatment within a community-based harm reduction service: a mixed methods evaluation.

ABSTRACT:

Background

Patient-centered approaches may facilitate retention in opioid agonist treatment (OAT) but are challenging to implement in rigid or stigmatizing service contexts. We evaluate a telemedicine program delivering flexible, patient-centered OAT from a community-based harm reduction setting in Montreal, Canada.

Methods

An OAT clinic was established in a community-based harm reduction setting with hospital-based addiction medicine services delivered remotely via telemedicine. Community workers screened clients, established telemedicine connections, and offered holistic patient follow-up. The medical team offered individualized OAT and other health services. Patients chose between treatment with methadone, buprenorphine/naloxone, or slow-release oral morphine. Hydromorpho

SUBMITTER: Hoj SB 

PROVIDER: S-EPMC12604225 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature